These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]. Silber S; Herdeg C Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314 [TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial. Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ; Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Stenestrand U; James SK; Lindbäck J; Fröbert O; Carlsson J; Scherstén F; Nilsson T; Lagerqvist B; Eur Heart J; 2010 Jan; 31(2):177-86. PubMed ID: 19903684 [TBL] [Abstract][Full Text] [Related]
8. Tackling complex cases in the drug-eluting stents era: where are we now? Holmes D J Invasive Cardiol; 2004 Sep; 16 Suppl F():8F-11F; discussion 18F-21F. PubMed ID: 23573647 [No Abstract] [Full Text] [Related]
9. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results. Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF; Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734 [TBL] [Abstract][Full Text] [Related]
11. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice? Byrne RA; Kastrati A EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727 [TBL] [Abstract][Full Text] [Related]
12. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography. Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303 [TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stents: a critique. Melikian N; Wijns W Heart; 2008 Feb; 94(2):145-52. PubMed ID: 18195121 [TBL] [Abstract][Full Text] [Related]
15. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents. Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029 [TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY). Valgimigli M; Campo G; Percoco G; Monti M; Ferrari F; Tumscitz C; Zuffi A; Colombo F; Kubbajeh M; Cavazza C; Cangiano E; Tebaldi M; Minarelli M; Arcozzi C; Scalone A; Frangione A; Borghesi M; Marchesini J; Parrinello G; Ferrari R Am Heart J; 2010 Nov; 160(5):804-11. PubMed ID: 21095265 [TBL] [Abstract][Full Text] [Related]
17. [A friend in need is a friend indeed: the case of drug-eluting stents, diabetes and small vessel size]. Kastrati A; Elezi S; Schömig A Rev Esp Cardiol; 2006 Oct; 59(10):991-3. PubMed ID: 17125706 [No Abstract] [Full Text] [Related]
18. Another small step for small vessels. Morrison DA Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195 [No Abstract] [Full Text] [Related]
19. Does stenting prevent diabetic arterial shrinkage after percutaneous coronary revascularization? Lincoff AM Circulation; 1997 Sep; 96(5):1374-7. PubMed ID: 9315518 [No Abstract] [Full Text] [Related]
20. PCI in small vessels: the case for a drug-coated balloon based intervention. Zeymer U; Scheller B EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729 [No Abstract] [Full Text] [Related] [Next] [New Search]